HLA matched

Related by string. * Hlaing . Hlad . Hlas . HLAs . Hla : Naw Ohn Hla . HLA typing . HLA B# . Hlaing Thar Yar . HLA A2 . Myint Hlaing . HLA DQ . lawyer Hla Myo . HLA alleles / Matching . Matched . matching . MATCH . matcher . MATCHING . Match . matchs : Match Play Championship . World Match Play . Pura Cup match . Sheffield Shield match . Accenture Match Play . Super Eights match . Match Play . matching wits * *

Related by context. All words. (Click for frequent words.) 73 HLA identical 67 allogeneic stem cell 67 allogenic 66 allogeneic transplants 65 CMV seropositive 65 allogeneic hematopoietic stem cell 65 autologous transplant 65 allogeneic 64 donor marrow 64 immunologically matched 63 allogeneic SCT 63 allogeneic transplant 63 autologous transplants 63 autologous SCT 62 receiving immunosuppressive therapy 62 syngeneic 62 granulocyte 62 allogeneic bone marrow 62 liver grafts 62 immunocompetent 62 haematopoietic 61 LRAT 61 Allogeneic 61 mutated K ras 61 renal transplants 61 undergoing hematopoietic stem 61 CMV infection 61 hematopoietic stem cell 61 kidney allograft 61 hematopoietic cell 60 human leukocyte antigens 60 haematopoietic stem cell 60 deletion 5q 60 chronic granulomatous disease 60 viremic 60 hepatectomy 60 allogeneic HSCT 60 HSCT 60 pancreatic islet 60 MELD scores 60 retransplantation 60 IVF embryo 60 gestational hypertension 60 HBsAg 60 HLA antigens 60 hA# 60 pretransplant 60 ECD kidneys 60 pluripotent embryonic 60 HBsAg positive 60 mouse testes 60 transplantation HSCT 60 HbF 59 Ribavirin causes 59 underwent liver transplantation 59 euthyroid 59 severe neutropenia 59 stem progenitor cells 59 renal allograft 59 immunodeficient 59 calcineurin inhibitor 59 transplantation HCT 59 vWD 59 SCIg 59 granulocytes 59 monozygotic twin 59 C#BL 6 mice 59 renal transplant 59 intravenous bolus 59 posttransplant 59 JAK3 59 immunosuppression therapy 59 recovery CRp 58 ADPKD 58 bronchoalveolar lavage fluid 58 mosaicism 58 hematopoietic cells 58 dizygotic twins 58 CD# + [001] 58 autologous transplantation 58 K ras mutations 58 pre eclamptic 58 basal cell nevus syndrome 58 crossmatch 58 graft dysfunction 58 immunosuppressive medication 58 thrombocytopenic 58 biochemical relapse 58 Gleevec resistant 58 bone marrow transplantations 58 pancreatic tissue 58 hepatorenal syndrome 58 HLA markers 58 stem cell engraftment 58 Rh positive 58 transfusion syndrome 58 anagrelide 58 arteriovenous fistula 58 cryopreserved 58 HepaMate 58 sCD# 58 stage IIIb IV 58 HLAs 58 transplanted islets 58 de novo kidney transplant 58 HBV infected 58 antibody titer 58 mutated KRAS 58 hematopoietic 58 pancreata 57 recurrent glioblastoma multiforme 57 Islet cells 57 myeloablative 57 leukapheresis 57 CR nPR 57 vWF 57 transplanted bone marrow 57 RhD negative 57 CsA 57 donor pancreases 57 mismatched bone marrow 57 renal cell carcinomas 57 PTLD 57 transplanted marrow 57 Umbilical cord stem cells 57 cells PBMC 57 severe congenital neutropenia 57 liver transplant recipients 57 RhD positive 57 CCR5 delta# 57 hMG 57 peripheral blood mononuclear 57 non mutated KRAS 57 renal transplantation 57 nutlin 3a 57 gastrointestinal stromal tumors GISTs 57 GRNOPC1 cells 57 Donated organs 57 CMV reactivation 57 immunosuppressive medications 57 APOL1 57 IgA deficiency 57 monocytic 57 ABO incompatible 57 5q deletion 57 fulminant hepatic failure 57 genes predisposing 57 IFN gamma 57 proband 57 platelet transfusion 57 Bone marrow transplant 57 Rh negative 57 relapsed MM 57 T1c 57 ERK1 2 57 pamidronate 57 nonidentical 57 allogenic stem cell 57 beta thalassemia 57 monozygotic 57 dyskeratosis congenita 57 CMV infections 57 vitamin B# folic acid 57 LDLT 57 unresectable recurrent 57 db db mice 56 MGd 56 immunosuppression 56 weekly subcutaneous injections 56 leukaemic cells 56 basiliximab 56 mesangial 56 nitroprusside 56 hematopoietic reconstitution 56 transgene expression 56 thrombocytopenic patients 56 mutant p# 56 prostate carcinoma 56 transplant HSCT 56 trophoblast cells 56 removed laparoscopically 56 donor livers 56 antithymocyte globulin 56 Islet transplantation 56 cisplatin resistant 56 nephron 56 adipose tissue derived 56 IVF ICSI 56 intensity allogeneic stem 56 glutamic acid decarboxylase 56 leukemia AML 56 tumor lysate 56 Clusterin 56 nonischemic 56 serum albumin 56 placental tissue 56 HepaGam B TM 56 paraganglioma 56 portal vein thrombosis 56 CD4 ^ sup 56 metastatic malignant 56 Leydig cells 56 bone marrow 56 leukemic blasts 56 BCL#A 56 gamma globin gene 56 myeloid 56 transgenic rats 56 bladder carcinoma 56 bone marrow derived mesenchymal 56 MLL gene 56 Adjuvant chemotherapy 56 abnormal hematopoietic cells 56 aplasia 56 immunosuppressed 56 microsatellite instability 56 Factor XIII 56 bone marrow stromal cells 56 mature oocytes 56 pancreatic ductal 56 sarcomatoid 56 lenalidomide Revlimid R 56 von Hippel Lindau 56 monozygotic twins 56 hematopoietic blood 56 extracorporeal membrane oxygenation 56 Rh factor 56 IFN alpha 56 fibroma 56 pancreatic endocrine 56 aneuploid 56 CMV disease 55 MSH2 55 cystic fibrosis chronic pancreatitis 55 Immunohistochemical analysis 55 transplanted kidneys 55 pancreatic adenocarcinoma 55 saline placebo 55 umbilical vein 55 kidney pancreas transplants 55 allogeneic hematopoietic cell 55 HCV infected 55 pancreatic islet cells 55 lymphoid organs 55 diagnosed prenatally 55 dizygotic 55 autologous bone marrow 55 radioiodine therapy 55 relapsed leukemia 55 rFVIIa 55 GRNOPC1 contains 55 acute GvHD 55 IFN ß 55 enucleated 55 Hematopoietic stem cell 55 placental stem cells 55 stromal vascular fraction 55 CD8 ^ sup 55 imatinib therapy 55 maternally inherited 55 Decitabine 55 anthracycline taxane 55 factor G CSF 55 adriamycin 55 Kinoid 55 Host Disease GvHD 55 Sertoli cells 55 chronic GVHD 55 autologous hematopoietic stem cell 55 PBMCs 55 autosomal recessive 55 leukemia ALL 55 peritoneal fluid 55 mononuclear cells 55 chimerism 55 8mg/kg 55 infarcted myocardium 55 human leukocyte antigen 55 triiodothyronine 55 immunological reactions 55 Hematopoietic stem cells 55 bone marrow stem cell 55 Alphanate R 55 acute myelogenous leukemia AML 55 TACI mutations 55 corticosteroid therapy 55 haematologic 55 Cojocaru correspondent 55 thyroglobulin 55 lymphocyte count 55 lung epithelium 55 ImmuKnow 55 aspartate aminotransferase AST 55 underwent resection 55 leukocyte count 55 GISTs 55 immunologically compatible 55 anthracycline chemotherapy 55 Carcinoid tumors 55 Hodgkin lymphoma HL 55 acute humoral rejection 55 maternal serum 55 cirrhotic 55 leukocytosis 55 receiving VICTRELIS 55 Th2 55 heterotaxy 55 congenital toxoplasmosis 55 relapsed ALL 55 randomly assigned cornea 55 fluvastatin 55 Islet cell 55 Inhaled nitric oxide 55 prostate adenocarcinoma 55 dilated cardiomyopathy DCM 55 cells hESCs 55 thymectomy 55 lymphocytic choriomeningitis virus LCMV 55 complete cytogenetic response 55 M. capricolum 55 cryo preserved 55 von Willebrand factor 55 Flu Cy 55 cellular immunotherapy 55 preeclamptic 55 bone marrow transplants 55 CD# + [002] 55 5-fluorouracil/leucovorin 55 cervical lymph nodes 55 L asparaginase 55 BALB c 55 rituximab Rituxan ® 55 tumoral 55 donor nephrectomy 55 de novo mutations 55 pDCs 55 Fibroblasts 55 cranial irradiation 55 oocyte retrieval 55 neutrophil counts 55 choroid plexus 54 Soluble CD# 54 Hurler syndrome 54 edifoligide 54 function DGF 54 ADAMTS# 54 engraftment 54 IgA antibodies 54 Circulating tumor cells 54 pancreatic resection 54 metastatic lung cancer 54 gonadotropins 54 luteal 54 Wilm tumor 54 lymphoblasts 54 daily subcutaneous injections 54 corpus luteum 54 Mitomycin C 54 postoperative complication 54 microgram kg 54 cadaveric donor 54 CMV vaccine 54 PTEN gene 54 porcine islets 54 AV fistulas 54 pancreatic islet cell 54 operable breast cancer 54 Doxil ® 54 #q# deletion syndrome 54 ovarian hyperstimulation 54 unresectable tumors 54 recurrent UTI 54 cytoreduction 54 orchitis 54 Progenitor cells 54 heterozygous 54 rhGH 54 mesalamine granules 54 insulin secreting beta 54 Ectopia Cordis 54 metastatic bladder 54 skeletal muscle cells 54 PPCM 54 cryoprecipitate 54 terminally differentiated 54 neoplastic 54 neuroblastomas 54 immunomodulatory therapy 54 Mild hypothermia 54 GPIIb IIIa 54 HER2 overexpression 54 CD8 + 54 thyrotropin 54 refractory chronic myeloid 54 reintubation 54 oocyte 54 MYLOTARG 54 gastrointestinal stromal tumor GIST 54 mesenchymal stem cell 54 HLA typing 54 MENOPUR ® 54 viral reactivation 54 HUCB cells 54 ganciclovir 54 insulin glulisine 54 intestinal polyps 54 JMML 54 mg/m2 dose 54 systemic ALCL 54 leukemic stem cells 54 HSPCs 54 renal fibrosis 54 colony stimulating factor 54 oocytes 54 progenitor cell 54 hypoperfusion 54 methotrexate therapy 54 glial derived neurotrophic 54 rHuEPO 54 Bezielle 54 IPAH 54 serum creatinine levels 54 supernatants 54 Waldenstrom macroglobulinemia 54 serum IGF 54 thrombocytosis 54 EXJADE 54 autoimmune hemolytic anemia 54 Myelodysplastic syndromes 54 lymphocytic 54 colorectal cancer liver metastases 54 heparanase 54 RBC transfusions 54 causative mutation 54 fertilized egg splits 54 cytomegalovirus CMV 54 multiple myeloma MM 54 autologous 54 hematologic disorders 54 neoplastic cells 54 undetectable HBV DNA 54 acinar 54 IVIG therapy 54 hematological parameters 54 Transplant Rejection 54 facilitates umbilical cord 54 mutant allele 54 egg retrieval 54 resected pancreatic cancer 54 Chronic myeloid leukemia CML 54 rhesus 54 xenograft 54 non myeloablative 54 preoperative chemotherapy 54 Fanconi syndrome 54 p# mutation 54 defective mitochondria 54 azoospermia 54 hESC lines 54 MLL AF9 54 adipose derived regenerative 54 skeletal myoblasts 54 HuCNS SC ® 54 adjuvant radiotherapy 54 decompensated cirrhosis 54 stem cell transplantation 54 CD8 + T 54 platelet transfusions 54 Sym# 54 interleukin IL -# 54 low dose cytarabine 54 beta islets 54 HLA DQ2 54 chromosomal defect 54 cadaveric organ 54 Adult Stem Cell Therapy 54 Ataluren 54 acceptor molecules 54 regenerative cells ADRCs 54 overt hypothyroidism 54 alkaline phosphatase 54 IRAK1 54 MYH9 gene 54 blastomeres 54 multipotent cells 54 immune suppressing 54 smoldering myeloma 54 ex vivo 54 myelomeningocele 54 HepaGam B 54 pegylated liposomal doxorubicin 54 Gamunex C 54 HUVEC 54 contractile muscle 54 hematopoietic stem cells HSCs 54 kappa B 53 inhibin 53 hemoglobin Hb 53 Mesenchymal 53 ependymoma 53 engrafted cells 53 megakaryocytes 53 neural cells 53 retroviral vectors 53 mixed hyperlipidemia 53 pyloric stenosis 53 diabetic rats 53 Liver transplantation 53 mutant alleles 53 IgG preparations 53 pancreatic islet beta 53 severely immunocompromised 53 IGFBP 3 53 alpha thalassemia 53 diphtheria pertussis whooping cough 53 μg ml 53 graft occlusion 53 busulfan 53 tumors GIST 53 CD8 + lymphocytes 53 intestinal mucosal 53 Foxp3 53 lymphocytic choriomeningitis virus 53 von Willebrand 53 corifollitropin alfa 53 nephrectomy 53 varicella zoster virus VZV 53 thymocytes 53 chronic hemodialysis 53 oral clodronate 53 hepatic metastases 53 vasopressor 53 clonogenic 53 intermittent hemodialysis 53 LEUKINE 53 oocytes eggs 53 DIPG 53 beta adrenergic receptor 53 toxic misfolded proteins 53 HIF 1a 53 azacytidine 53 azacitidine 53 p# activation 53 pancreases 53 uncoupling protein 53 renovascular hypertension 53 intracytoplasmic sperm injection 53 ovulation induction 53 Myelodysplastic Syndrome 53 RPE# 53 folinic acid 53 eppin 53 transplant ASCT 53 MYDICAR ® 53 T1DM 53 transplanted liver 53 Madin Darby canine 53 nucleoside naive patients 53 HER2 receptor 53 idiopathic thrombocytopenic purpura ITP 53 HAART regimen 53 lactate dehydrogenase LDH 53 HeartMate XVE 53 intravenous immunoglobulin 53 Taliglucerase alfa 53 TTF Therapy 53 coagulation factors 53 either acutely decompensated 53 chemoembolization 53 VHL gene 53 PNET 53 hematopoietic progenitors 53 Extracting stem cells 53 lung adenocarcinomas 53 β cell 53 adrenocorticotropic hormone 53 bone marrow lymph nodes 53 LHRH agonists 53 Mitral valve repair 53 induce pluripotency 53 multiorgan 53 leukaemias 53 aromatase inhibitor therapy 53 skeletal metastases 53 ductal adenocarcinoma 53 diploid 53 sleeve lobectomy 53 microchimerism 53 engineered bladders 53 primordial germ cells 53 via intradermal injections 53 pDC 53 Mycoplasma capricolum 53 marrow transplant 53 sFlt 1 53 Kit CD# positive 53 chromosome #q#.# [001] 53 stem cell transplant 53 cisplatin chemotherapy 53 radical nephrectomy 53 IgGs 53 secretes insulin 53 coexpression 53 lobule 53 underwent surgical resection 53 recombinant FSH 53 GBM tumors 53 effector function 53 RAS blockers 53 atherosclerotic lesions 53 CD8 T cells 53 adult mesenchymal stem 53 colonic mucosa 53 cybrid 53 LVAS 53 PSA nadir 53 plasma folate 53 secondary amenorrhea 53 lactate dehydrogenase 53 orthotopic 53 tetanus toxoid 53 partial remissions 53 Surgical resection 53 immature dendritic cells 53 oligodendrocyte progenitor cells 53 adverse cytogenetics 53 Alport syndrome 53 ovulatory cycles 53 MeCP2 gene 53 CHD7 53 aHUS 53 TNFalpha 53 left ventricular systolic 53 ovarian stimulation 53 endometritis 53 Lung transplantation 53 PNH patients 53 atypical Hemolytic Uremic Syndrome 53 lutropin alfa 53 steroid refractory 53 B. fragilis 53 GnRH agonist 53 CYP#B# 53 ejection fractions 53 placenta praevia 53 Jurkat cells 53 hemolytic disease 53 Myelosuppression 53 CFTR gene 53 interleukin IL -6 53 activin 53 nonischemic cardiomyopathy 53 reinfusion 53 CIMZIA TM 53 subcutaneous infusion 53 Fragile X mental retardation 53 cervical carcinoma 53 moderate immunologic 53 B7 H3 53 stem cells harvested 53 NGAL 53 4mg/kg 53 juvenile myelomonocytic leukemia 53 Olerup SSP 53 NF1 53 HIV HCV coinfected 53 malignant prostate 53 Index CDAI 53 bolus dose 53 P selectin 53 potentially hepatotoxic 53 kidneys transplanted 53 multivariable analysis 53 erythrocytes 53 chemoradiation therapy 53 breast carcinomas 53 SMN1 53 cardiac fibroblasts 53 progesterone deficiency 53 TOP2A 53 transplanted livers 53 acute myeloid 53 donor cornea 53 patient allogeneic 53 lymphocyte counts 53 peritoneal carcinomatosis 53 Epstein Barr virus EBV 53 Autologous 53 Allogeneic stem cell 53 TNF alpha antagonist 53 immune reconstitution 53 Gliadel Wafer 53 interferon IFN 53 Heavy menstrual bleeding 53 revascularization procedure 53 pituitary hormone 53 M1 macrophages 53 ID TLR 53 visilizumab 53 Akt1 53 herpesviruses 53 peritoneal cancer 53 Ab# 53 Diamond Blackfan anemia 53 pulmonary artery banding 53 dialed Ybarra 53 lymphoid 53 nondiabetic patients 52 matching marrow donor 52 neonate 52 histocompatibility 52 FVIII 52 Tacrolimus 52 Autologous stem cell 52 HepaMate ™ 52 poloxamer 52 mouse neural stem 52 myoblasts 52 systolic dysfunction 52 IUGR 52 systemic hypotension 52 HUCB 52 testicular germ cell 52 B lymphocyte 52 IV tPA 52 thrombotic complications 52 pCR 52 neurofibromin 52 abnormal chromosomes 52 adipose derived stem cells 52 egg follicles 52 thymic carcinoma 52 TNF α 52 cystectomy 52 nicardipine 52 novel VDA molecule 52 peginterferon alfa 52 iPSC lines 52 erythropoiesis 52 gastrointestinal stromal tumors GIST 52 combining voreloxin 52 familial hypercholesterolemia FH 52 intravenous immunoglobulin IVIg 52 immunosuppressant medications 52 baseline LDH 52 teratoma 52 Von Willebrand disease 52 umbilical cord stem cells 52 multi incision laparoscopic 52 Liver transplant 52 preintervention 52 hematopoietic progenitor cells 52 erythropoietic 52 alanine aminotransferase ALT 52 haematological 52 oligohydramnios 52 recessive mutation 52 RBC transfusion 52 Placental 52 thymic 52 leukemic cell 52 ovarian hyperstimulation syndrome OHSS 52 Helicobacter infection 52 intracranial hemorrhage ICH 52 docetaxel chemotherapy 52 mesenchymal stem cells MSCs 52 pancreatic islets 52 vincristine 52 recurrent ovarian 52 cerebral vasospasm 52 baseline Hb 52 corneal graft 52 hepatocytes 52 symptomatic hypotension 52 posttranslational modification 52 inactivated vaccine 52 advanced neoplasia 52 Immunosuppressive drugs 52 amniotic epithelial cells 52 stem cells MSCs 52 CTAP# Capsules 52 inducible nitric oxide synthase 52 OMP #R# 52 Treg cell 52 MENOPUR 52 % CI #.#-#.# [005] 52 insulin secreting 52 dose melphalan 52 HBV vaccination 52 factor PlGF 52 colorectal liver metastases 52 VEGF expression 52 administered intranasally 52 WT1 52 missense mutations 52 Acute Myeloid Leukaemia AML 52 platelets plasma 52 insulin secreting cells 52 Wilms tumors 52 cerebri 52 Idiopathic Thrombocytopenic Purpura ITP 52 octreotide LAR 52 liver histology 52 liver metastases 52 lymphoid tissue 52 factor TNF receptor 52 RhD 52 ascending dose 52 leukemia CLL 52 exocrine 52 serum calcium levels 52 AV grafts 52 pancreatic transplantation 52 anovulation 52 preeclamptic women 52 BRIP1 52 Chronic lymphocytic leukemia 52 Hepatocellular Carcinoma HCC 52 short bowel syndrome 52 myeloproliferative neoplasms 52 immunosuppressive regimen 52 caspofungin 52 miglustat 52 isoenzyme 52 Belatacept 52 immunologically 52 aprepitant 52 SMN protein 52 suppressor cells 52 germline mutations 52 immuno suppressive drugs 52 progenitor cells derived 52 porcine derived 52 Hematopoietic 52 amnion 52 pro angiogenic 52 nonalcoholic cirrhosis 52 autologous cells 52 transplanted islet cells 52 nonmetastatic 52 IFN beta 52 autologous stem cell 52 carcinoma HCC 52 mammary gland tumors 52 systemic corticosteroid 52 elevated serum ALT 52 varicocele 52 C1 INH 52 divide asymmetrically 52 glomerular 52 NMDP registry 52 genotoxic stress 52 NF kB pathway 52 Retrograde ejaculation 52 Follistim 52 NAGS deficiency 52 MMP9 52 proliferative retinopathy 52 nonmyeloablative 52 keratinocyte 52 visit www.marrow.org 52 diagnosed glioblastoma multiforme 52 inhaled nitric oxide 52 Fc receptor 52 anterior pituitary 52 beta blocker therapy 52 adjuvant radiation 52 metastatic malignant melanoma 52 Aptivus ® 52 ofpatients 52 sibling grandparent 52 clot busting therapy 52 bcl 2 52 IR Cysteamine 52 cellularity 52 inherited mutations 52 calcineurin 52 thyrotropin levels 52 Rh incompatibility 52 thrombophilia 52 pharmacologically active isomer 52 decompensated heart failure 52 annexin V 52 transfusion transmitted 52 fibroblast cells 52 Th1 cells 52 Zavesca R 52 myelin reactive T 52 TEL AML1 52 SUPPRELIN R LA 52 iNOS 52 unmethylated 52 shortened telomeres 52 cytomegalovirus 52 antidiuretic hormone 52 familial pancreatic cancer 52 metastatic RCC 52 immunosuppressive regimens 52 TNFa 52 extrahepatic 52 GvHD 52 refractory acute myeloid 52 Alagille syndrome 52 idarubicin 52 revascularized 52 mycophenolate 52 bone marrow transplant 52 LQTS 52 Pathway Inhibitor 52 IL 1ß 52 immune globulins 52 FUSILEV enhances 52 nephritis 52 reproductive endocrine 52 RSV bronchiolitis 52 pulmonary hypoplasia 52 mice lacking 52 postoperative chemotherapy 52 Apheresis 52 chromosomally abnormal 52 orthotopic liver transplantation 52 thyroid hormone replacement 52 persistent pulmonary hypertension 52 adrenalectomy 52 immune modulator 52 congenital disorders 52 serum lipid levels 52 hemolytic 52 stem cell transplantations 52 intestinal biopsy 52 Fanconi Anemia 52 transfusion 52 hepatoblastoma 52 holoprosencephaly 52 gonadotropin releasing hormone GnRH 52 Benign tumors 52 standard chemotherapy regimens 52 polycystic kidneys 52 Acute myeloid leukemia 52 CD4 + T lymphocytes 52 anthracyclines taxanes 52 Peg IFN 52 debulking surgery 52 NRTI backbone 52 artery embolization 52 CHOP chemotherapy 52 metabolomic profiles 52 neuroendocrine cancers 52 singleton pregnancy 52 Velcade bortezomib 52 standard immunosuppressive therapies 52 transplant HSCT recipients 52 EGFP 52 myeloma cells 52 hepatocyte 52 Aß# 52 MECP2 gene 52 ER CHOP 52 ovarian follicles 52 solid organ transplantation 52 medulloblastoma tumors 52 hematopoietic stem cells 52 recurrent NSCLC 52 CANCIDAS 52 cerebral angiography 52 systemic corticosteroids 52 Hirschsprung disease 52 thalassemia trait 52 steroid refractory ulcerative 52 gastric carcinomas 52 maternal antibodies 52 Allograft 51 glycated hemoglobin levels 51 sperm donor offspring 51 mCi kg 51 clinico pathological 51 histological subtype 51 malignant polyps 51 Umbilical cord blood 51 autosomal dominant polycystic kidney 51 differential gene expression 51 Thymoglobulin ® 51 FXIII 51 CD4 + T 51 Tumors shrank 51 BRAF gene 51 dedifferentiation 51 Acute renal failure 51 multipotent 51 erythroid 51 CD4 + cells 51 inotropic 51 unfertilised eggs 51 leukemias lymphomas 51 glucocerebrosidase 51 stem cell pluripotency 51 glial tumors 51 ß amyloid 51 T lymphocyte

Back to home page